Edition:
United Kingdom

Trevena Inc (TRVN.OQ)

TRVN.OQ on NASDAQ Stock Exchange Global Select Market

1.75USD
18 Apr 2018
Change (% chg)

-- (--)
Prev Close
$1.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
191,209
52-wk High
$3.63
52-wk Low
$1.35

Chart for

About

Trevena Inc. is a biopharmaceutical company, which is engaged in developing various therapies. The Company is developing OLINVO, a u-receptor G protein pathway selective modulator (u-GPS) for the management of moderate-to-severe acute pain where intravenous (IV) administration is preferred. It is focused on commercializing it in... (more)

Overall

Beta: -0.51
Market Cap(Mil.): $117.17
Shares Outstanding(Mil.): 66.95
Dividend: --
Yield (%): --

Financials

  TRVN.OQ Industry Sector
P/E (TTM): -- 199.23 33.50
EPS (TTM): -1.22 -- --
ROI: -97.70 -0.66 13.17
ROE: -126.95 -2.84 14.98

BRIEF-Trevena Says Chief Financial Officer Roberto Cuca Will Resign, Effective May 3, 2018

* TREVENA SAYS ON APRIL 9, ROBERTO CUCA, CHIEF FINANCIAL OFFICER OF CO FORMALLY NOTIFIED CO OF HIS RESIGNATION, EFFECTIVE AS OF MAY 3, 2018 - SEC FILING Source text: (https://bit.ly/2GVszsP) Further company coverage:

12 Apr 2018

BRIEF-Trevena Reports Q4 Loss Per Share $0.24

* COMPANY EXPECTS THAT EXPENSES WILL DECREASE IN 2018 COMPARED TO 2017

07 Mar 2018

BRIEF-Trevena Inc Says FDA Indicated To Co That PDUFA Date For Olinvo NDA Is Nov 2‍​

* TREVENA INC - ON JAN 5, FDA INDICATED TO THE CO THAT PDUFA REVIEW DATE FOR OLINVO NDA IS NOV 2‍​

05 Jan 2018

BRIEF-Trevena Announces FDA Acceptance For Review Of New Drug Application For OLINVO(Oliceridine) Injection

* TREVENA ANNOUNCES FDA ACCEPTANCE FOR REVIEW OF NEW DRUG APPLICATION FOR OLINVO (OLICERIDINE) INJECTION

02 Jan 2018

BRIEF-Trevena Inc says Q3 loss per share $0.27

* Trevena reports third quarter 2017 financial results and announces new positive clinical trial data

07 Nov 2017

BRIEF-Trevena announces submission of NDA to U.S. FDA for Olinvo

* Trevena announces submission of new drug application to U.S. FDA for Olinvo (oliceridine injection)

02 Nov 2017

BRIEF-‍trevena announces publication and presentations of olinvo clinical data​

* ‍Trevena announces publication and presentations of olinvo (oliceridine injection) clinical data​ Source text for Eikon: Further company coverage:

25 Oct 2017

Earnings vs. Estimates